Pharma Journalist 8962 posts 0 comments

Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors.…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson confirmed positive topline results from the global, Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS)…
Read More...

Myanmar Phar-Med Expo 2018 is the 6th International Exhibition and Conference on Pharmaceutical, Medical, Laboratory and Dental Industry for Myanmar with over 80 exhibitions from 15…
Read More...

Cambodia Phar-med Expo 2018 is the 4th International Exhibition and Conference on Pharmaceutical, Medical, Laboratory and Dental Industry for Cambodia with over 60 exhibitors from 15…
Read More...

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. announced that it has acquired certain patents and patent applications from Escape Therapeutics relating primarily to the use of…
Read More...

WuXi AppTec Research Service Division and Cyclica announced a multi-phase collaboration to advance drug discovery programs by driving insights into small molecule polypharmacology,…
Read More...

Novocure and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in…
Read More...

Altasciences announced that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A. The transaction is expected to be completed at the end of…
Read More...

Agenus Inc, an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced that Merck, known as MSD outside…
Read More...

Onspira Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational product, OSP-101, for the treatment of…
Read More...